Association of the polymorphisms in NURR1 gene with Parkinson's disease

Chinese Journal of Medical Genetics

Volumn 25, Issue 6, 2008, Pages 693-696

  Wu, Yan ^a   Peng, Rong ^a   Chen, Wen Jun ^a   Zhang, Jin Hong ^a   Li, Tao ^a,b   Wang, Ying Cheng ^a   Gou, Ying Ru ^a   Yuan, Guang Gu ^a  

^a SICHUAN UNIVERSITY   (China)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Genetic polymorphism; NURR1 gene; Parkinson's disease

Indexed keywords

NUCLEAR RECEPTOR RELATED FACTOR 1;

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DNA POLYMORPHISM; ETHNICITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PROMOTER REGION;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, GENETIC; SEX FACTORS; TRANSCRIPTION FACTORS;

EID: 57849092691     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Zetterstrom RH, Solomin L, Jansson L, et al. Dopamine neuron agenesis in Nurr1-deficient mice. Science, 1997,276:248-250.
2. Castillo SO, Baffi JS, Palkovits M, et al. Dopamine biosynthesis is selectively abolished in substantia nigra/ventral tegmental area but not in hypothalamic neurons in mice with targeted disruption of the Nurr1 gene. Mol Cell Neurosci, 1998,11:36-46.
3. Meara J, Bhowmick BK, Hobson P, et al. Accuracy of diagnosis in patients with presumed Parkinson's disease. Age Ageing, 1999,28:99-102.
4. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry, 1992,55:181-184.
5. Yan ZQ, Tong Q, Wang F, et al. Use of a rapid mismatch PCR method to detect gyrA and parC mutation in ciprofloacin-resistant clinical isolates of Escherichia coli. J Antimicrob Chemother, 2002,49:549-552.
6. Zhang T, Jia N, Fei E, et al. Nurr1 is phosphorylated by ERK2 in vitro and its phosphorylation upregulates tyrosine hydroxylase expression in SHSY5Y cells. Neurosci Lett, 2007,423:118-122.
7. Park CH, Kang JS, Shin YH, et al. Acquisition of in vitro and in vivo functionality of Nurr1-induced dopamine neurons. FASEB J, 2006,20:2553-2555.
8. Xu PY, Liang R, Jankovic J, et al. Association of homozygous 7048G7049 variant in the intron six of Nurr1 gene with Parkinson's disease. Neurology, 2002,58:881-884.
9. Zheng K, Heydari B, Simon DK, et al. A commun NURR1 polymorphism associated with Parkinson disease and diffuse Lewy body disease. Arch Neurol, 2003,60:722-725.
10. Healy DG, Abou-Sleiman PM, Ahmadi KR, et al. NR4A2 genetic variation in sporadic Parkinson's disease: a genewide approach. Mov Disord, 2006,21:1960-1963.
11. Hering R, Petrovic S, Mietz EM, et al. Extended mutation analysis and association studies of Nurr1 (NR4A2) in Parkinson disease. Neurology, 2004,62:1231-1232.
12. Tan EK, Chung H, Zhao Y, et al. Genetic analysis of Nurr1 haplotypes in Parkinson's disease. Neurosci Lett, 2003,347:139-142.
13. Chen CM, Chen IC, Chang KH, et al. Nuclear receptor NK4A2 IVS6 + 18insG and brain derived neurotrophic factor (BDNF) V66M polymorphisms and risk of Taiwanese Parkinson's disease. Am J Med Genet B Neuropsychiatr Genet, 2007,144:458-462.
14. O'Neill JP, Rogan PK, Cariello N, et al. Mutations that alter RNA splicing of the human HPRT gene: a review of the spectrum. Mut Res, 1998, 411:179-214.
15. Carmine A, Buervenich S, Gailter D, et al. NURR1 promoter polymorphisms: Parkinson's disease, schizophrenia, and personality traits. Am J Med Genet B Neuropsychiatr Genet, 2003,120:51-57.
16. Le WD, Xu P, Jankovic J, et al. Mutations in NR4A2 associated with familial Parkinson disease. Nat Genet, 2003,33:85-89.